Stock Forecast Based On a Predictive Algorithm | I Know First |Best pharma stocks Archives - Stock Forecast Based On a Predictive Algorithm

Since the beginning of 2018 Arrowhead Pharmaceuticals showed growth catalysts for this year. First, according to the quarterly report for the period ended December 31, 2017, on September 28, 2016 the Company entered into a collaboration agreement with Amgen Inc. The Company received a worldwide license for ARO-AMG1, an RNAi therapy for an undisclosed genetically validated cardiovascular target, that makes Amgen wholly responsible for clinical development and commercialization of this technology. Moreover, the

Winning Stock Forecast

Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock

July 1, 2018

This article was written by Grant Goldstein, a Financial Analyst at I Know First

Highlights:

Regeneron has Underwhelming Q1 Financials
REGN is Undervalued
I Know First Bullish Forecast for REGN

I Know First.

Read The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Biotech Stocks Forecast Healthcare Premium Articles

Winning AVXL Stock Forecast: Life Changing Treatment Discoveries and M&A Expectations Add Value to Avanex

June 11, 2018

“We are looking forward, focusing on executing clinical trials using the inclusion of advanced genomic biomarkers into late-stage CNS precision medicine trials, including our Rett syndrome, Alzheimer’s disease and Parkinson’s disease dementia trials – all indications with high unmet need”

-Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a biopharmaceutical company focused on using genetic medicine to treat neurodegenerative and neurodevelopmental diseases, such as Alzheimer’s disease

Stock Forecast & S&P500 Forecast Winning Stock Forecast